TipRanks
Go Ultimate55% OFF

Christopher Ryan Sullivan Insider Profile

4 Followers

Christopher Ryan Sullivan, CFO at Avalo Therapeutics, holds 39.90K shares in Avalo Therapeutics (Ticker: AVTX).

Christopher Ryan Sullivan's Trading History

AVTX
Avalo Therapeutics
Sep 18, 2026CFOUninformative Buy122.45K$286.08K
AVTX
Insider Shares: 39.90K (0.07%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 18, 2026Uninformative Sell$202.39K12,394$16.33―
Sep 18, 2026Uninformative Buy$122.45K12,394$9.88―
Sep 11, 2026Uninformative Sell$179.36K10,185$17.61―
Sep 11, 2026Uninformative Buy$81.89K10,185$8.04―
Aug 19, 2026Informative Sell$696.93K34,780$20.03―

You May Also Like

Christopher Ryan Sullivan insider profile FAQ

What stocks does Christopher Ryan Sullivan hold?
Christopher Ryan Sullivan holds: AVTX stocks.
What was Christopher Ryan Sullivan’s latest transaction?
Christopher Ryan Sullivan’s latest transaction was an Uninformative Buy of $122.45K.
What is Christopher Ryan Sullivan's role in Avalo Therapeutics?
Christopher Ryan Sullivan's role in Avalo Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.